Clofazimine does not lead to significant QT interval prolongation: a multicentre study

Eur Respir J. 2018 Nov 1;52(5):1801386. doi: 10.1183/13993003.01386-2018. Print 2018 Nov.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Arrhythmias, Cardiac
  • Clofazimine*
  • Diarylquinolines
  • Heart
  • Humans
  • Long QT Syndrome*

Substances

  • Diarylquinolines
  • bedaquiline
  • Clofazimine